Alopecia Induced by Dopamine Agonists
Neurol 58:829-830, Tabamo,R.E. &Di Rocco,A., 2002
The Neurological Masquerade of Intravascular Lymphomatosis
Arch Neurol 59:439-443, Beristain,X.&Azzarelli,B., 2002
Chronic Inflammatory Demyelinating Polyneuropathy Presenting with Features of GBS
Neurol 58:979-982, Mori,K.,et al, 2002
Central Nervous System Infection in Congenital Syphilis
NEJM 346:1792-1798, Michelow,I.C.,et al, 2002
Donepezil for Cognitive Impairment in Parkinson's Disease: A Randomised Controlled Study
JNNP 72:708-712, Aarsland,D.,et al, 2002
Incidence and Prediction of Falls in Parkinson's Disease: A Prospecitve Multidisciplinary Study
JNNP 72:721-725, Wood,B.H.,et al, 2002
A Forearm Exercise Screening Test for Mitochondrial Myopathy
Neurol 58:1533-1538, Jensen,T.D.,et al, 2002
Therapies for Movement Disorders
Arch Neurol 59:699-702, Goetz,C.G &Hinson,V.K., 2002
Treatment Interventions for Parkinson's Disease: An Evidence Based Assessment
Lancet 359:1589-1598, Rascol,O.,et al, 2002
New Strategy for Prenatal Diagnosis of X-Linked Disorders
NEJM 346:1502, Costa,J.,et al, 2002
Alzheimer Disease
JAMA 287:2335-2338, Cummings,J.L. &Cole,G., 2002
Impact of Sustained Deprenyl (Selegiline) in Levodopa-Treated Parkinson's Disease: A Randomized Placebo-Controlled Extension of the Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism Trial
Ann Nuerol 51:604-612, Shoulson,I.,et al, 2002
Management of Acute Optic Neuritis
Lancet 360:1953-1962, Hickman,S.J.,et al, 2002
Bilateral Subthalamic Nucleus Stimulation Improves Health-Related Quality of Life in PD
Neurol 59:1976-1978, Lagrange,E.,et al, 2002
Botulinum Toxin for Cricopharyngeal Dysfunction in Parkinson's Disease
NEJM 346:1174-1175, Restivo,D.A.,et al, 2002
Familial Dementia With Lewy Bodies
Arch Neurol 59:1622-1630, Tsuang,D.W.,et al, 2002
The Role of Cerebrospinal Fluid Hypocretin Measurement in the Diagnosis of Narcolepsy and Other Hypersomnias
Arch Neurol 59:1553-1562, Mignot,E.,et al, 2002
Mitochondrial Therapy for Parkinson Disease
Arch Neurol 59:1523, Rosenberg,R.N., 2002
Potentially Reversible Conditions in 1000 Consecutive Memory Clinic Patients
JNNP 73:390-394, Hejl,A.,et al, 2002
Vein of Galen Aneurysmal Malformation: Diagnosis and Treatment of 13 Children With Extended Clinical Follow-Up
AJNR 23:1717-1724, Jones,B.V.,et al, 2002
Diagnostic Strategies in Vasculitis Affecting the Central Nervous System
Cleve Clin J Med 69:SII 105-108, Calabrese,L.H., 2002
A Practical Approach to the Diagnosis and Management of MELAS: Case Report and Review
The Neurologist 8:302-312, Thambisetty,M.,et al, 2002
Diagnosis and Surgical Management of Cervical Ossification of the Posterior Longitudinal Ligament
Spine J 2:436-439, Epstein,N., 2002
Mycoplasma Pneumoniae Encephalitis in Childhood
J Microbiol Immunol Infect 35:173-178, Lin,W.-C., et al, 2002
Subacute Sclerosing Panencephalitis
Postgrad Med J 78:63-70, Garg, R.K.,et al, 2002
HIV-Related Movement Disorders, Epidemiology, Pathogenesis and Management
CNS Drugs 16:663-668, Cardoso,F., 2002
Daytime Sleepiness and Other Sleep Disorders in Parkinson's Disease
Neurol 57:1392-1396, Ondo,W.G.,et al, 2001
Precipitating Factors in Pituitary Apoplexy
JNNP 71:542-545, Biousse,V.,et al, 2001
Hallucinations in Parkinson's Disease
Lancet 358:1031-1032, Korczyn,A.D., 2001
Ten-year Follow-up of Three Different Initial Treatments in De-novo PD
Neurol 57:1687-1694, Lees,A.J.,et al, 2001
Complete Genomic Screen in Parkinson Disease
JAMA 286:2239-2244, Scott,W.K.,et al, 2001
Stereotactic Stimulation of Posterior Hypothalamic Gray Matter in a patient with Intractable Cluster Headache
NEJM 345:1428-1429, Leone,M.,et al, 2001
Positron Emission Tomography in Evaluation of Dementia
JAMA 286:2120-2127,2194, Silverman,D.H.S.,et al, 2001
Fluid-Attenuated Inversion Recovery and Diffusion- and Perfusion-Weighted MRI Abnormalities in 117 Consecutive Patients with Stroke Symptoms
Stroke 32:2774-2781, Perkins,C.J.,et al, 2001
Complications of Gamma Knife Surgery for Parkinson Disease
Arch Neurol 58:1995-2002,1970, Okun,M.S.,et al, 2001
[123I]Beta-CIT SPECT Imaging Assessment of the Rate of Parkinson's Disease Progression
Neurol 57:2089-2094, Marek,K.,et al, 2001
Surgical Therapy for Tremor in Multiple Sclerosis
Neurol 57:1876-1882, Matsumoto,J.,et al, 2001
Spinocerebellar Ataxia Type 2 Presenting as Familial Levodopa-Responsive Parkinsonism
Ann Neurol 50:812-815, Shan,D.,et al, 2001
CSF Hypocretin/Orexin Levels in Narcolepsy and Other Neurological Conditions
Neurol 57:2253-2258, Ripley,B.,et al, 2001
Use of 14-3-3 and Other Brain-specific Proteins in CSF in the Diagnosis of Variant Creutzfeldt-Jakob Disease
JNNP 70:744-748, Green,A.J.E.,et al, 2001
Toxic Leukoencephalopathy
NEJM 345:425-432, Filley,C.M. &Kleinschmidt-DeMasters,B.K., 2001
Inclusiong Body Myositis Mimicking Motor Neuron Disease
Arch Neurol 58:1253-1256, Dabby,R.,et al, 2001
Effects of Bilateral Subthalamic Stimulation on Cognitive Function in Parkinson Disease
Arch Neurol 58:1223-1227,1205, Alegret,M.,et al, 2001
Bilateral Pallidal Deep Brain Stimulation for Cervical and Truncal Dystonia
Neurol 57:557-558, Andaluz,N.,et al, 2001
Cervical MR Imaging in Postural Headache: MR Signs and Pathophysiological Implications
AJNR 22:1239-1250,1233, Yousry,I.,et al, 2001
Quantitation of 14-3-3 and Neurol-Specific Enolase Proteins in CSF in Creutzfeldt-Jakob Disease
Neurol 57:728-730, Aksamit,A.L.,et al, 2001
Deep Brain Stimulation in the Treatment of Parkinson's Disease,A Cost-Effectiveness Analysis
Neurol 57:663-671, Tomaszewski,K.J.&Holloway,R.G., 2001
Diffusion-Weighted MR Imaging of Rim-Enhancing Brain Masses:Is Markedly Decreased Water Diffusion Specific for Brain Abscess?
AJR 177:709-712, Tung,G.A., 2001
Comtan (Entacapone) The Treatment of Parkinson's Disease, Questions & Answers
APDA Ed Suppl #15, Watts,R.L., 2001
A randomized,Double-blind,Placebo-Controlled Trial of Subcutaneously Injected Apomorphine for Parkinsonian Off-State Events
Arch Neurol 58:1385-1392, Dewey,R.B.,et al, 2001